Masayon, Rizalyn C.
HRN: 20-83-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2023
CEFUROXIME 500MG (TAB)
11/05/2023
11/11/2023
ORAL
500mg
BID
Thinly MSAF
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes